220 related articles for article (PubMed ID: 15280627)
1. Association of the California tobacco control program with declines in lung cancer incidence.
Barnoya J; Glantz S
Cancer Causes Control; 2004 Sep; 15(7):689-95. PubMed ID: 15280627
[TBL] [Abstract][Full Text] [Related]
2. Declines in lung cancer rates--California, 1988-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(47):1066-9. PubMed ID: 11186612
[TBL] [Abstract][Full Text] [Related]
3. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.
Fichtenberg CM; Glantz SA
N Engl J Med; 2000 Dec; 343(24):1772-7. PubMed ID: 11114317
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer incidence trends by histologic type in areas of California vs. other areas in the Surveillance, Epidemiology and End Results Program.
Polednak AP
Cancer Epidemiol; 2009 Nov; 33(5):319-24. PubMed ID: 19910276
[TBL] [Abstract][Full Text] [Related]
5. State-specific trends in lung cancer incidence and smoking--United States, 1999-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(36):1243-7. PubMed ID: 21918494
[TBL] [Abstract][Full Text] [Related]
6. Contemporary lung cancer trends among U.S. women.
Jemal A; Ward E; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):582-5. PubMed ID: 15767333
[TBL] [Abstract][Full Text] [Related]
7. Forty years of faster decline in cigarette smoking in California explains current lower lung cancer rates.
Pierce JP; Messer K; White MM; Kealey S; Cowling DW
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2801-10. PubMed ID: 20852009
[TBL] [Abstract][Full Text] [Related]
8. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
9. Reduced lung cancer deaths attributable to decreased tobacco use in Massachusetts.
Kabir Z; Connolly GN; Clancy L; Jemal A; Koh HK
Cancer Causes Control; 2007 Oct; 18(8):833-8. PubMed ID: 17588154
[TBL] [Abstract][Full Text] [Related]
10. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
11. California as a model.
Bal DG; Lloyd JC; Roeseler A; Shimizu R
J Clin Oncol; 2001 Sep; 19(18 Suppl):69S-73S. PubMed ID: 11560977
[TBL] [Abstract][Full Text] [Related]
12. Increasing lung cancer incidence among Israeli Arab men reflects a change in the earlier paradox of low incidence and high smoking prevalence.
Tarabeia J; Green MS; Barchana M; Baron-Epel O; Ifrah A; Fishler Y; Nitzan-Kaluski D
Eur J Cancer Prev; 2008 Aug; 17(4):291-6. PubMed ID: 18562951
[TBL] [Abstract][Full Text] [Related]
13. Geographic pattern of cancers related to tobacco and alcohol in Connecticut: implications for cancer control.
Polednak AP
Cancer Detect Prev; 2004; 28(4):302-8. PubMed ID: 15350634
[TBL] [Abstract][Full Text] [Related]
14. Incidence of oral cavity and pharynx cancer in Kentucky.
Huang B; Valentino J; Wyatt SW; Gal TJ
J Ky Med Assoc; 2008 Aug; 106(8):355-60. PubMed ID: 18783038
[TBL] [Abstract][Full Text] [Related]
15. Mortality from lung cancer and tobacco smoking in Ohio (U.S.): will increasing smoking prevalence reverse current decreases in mortality?
Tyczynski JE; Berkel HJ
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1182-7. PubMed ID: 15894669
[TBL] [Abstract][Full Text] [Related]
16. Regional variations in breast cancer incidence among California women, 1988-1997.
Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
[TBL] [Abstract][Full Text] [Related]
17. [The beginning of the end of the lung cancer epidemic among Dutch women].
Karim-Kos HE; Janssen-Heijnen ML; van Iersel CA; van der Meer RM; de Vries E; Coebergh JW
Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1473-7. PubMed ID: 18666666
[TBL] [Abstract][Full Text] [Related]
18. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
19. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
20. Trends in Missouri lung cancer rates.
Miller N; Simoes EJ; Chang JC
Mo Med; 1999 Feb; 96(2):57-61. PubMed ID: 10036914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
